Literature DB >> 23913046

Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens.

Ansuman T Satpathy1, Carlos G Briseño, Jacob S Lee, Dennis Ng, Nicholas A Manieri, Wumesh Kc, Xiaodi Wu, Stephanie R Thomas, Wan-Ling Lee, Mustafa Turkoz, Keely G McDonald, Matthew M Meredith, Christina Song, Cynthia J Guidos, Rodney D Newberry, Wenjun Ouyang, Theresa L Murphy, Thaddeus S Stappenbeck, Jennifer L Gommerman, Michel C Nussenzweig, Marco Colonna, Raphael Kopan, Kenneth M Murphy.   

Abstract

Defense against attaching-and-effacing bacteria requires the sequential generation of interleukin 23 (IL-23) and IL-22 to induce protective mucosal responses. Although CD4(+) and NKp46(+) innate lymphoid cells (ILCs) are the critical source of IL-22 during infection, the precise source of IL-23 is unclear. We used genetic techniques to deplete mice of specific subsets of classical dendritic cells (cDCs) and analyzed immunity to the attaching-and-effacing pathogen Citrobacter rodentium. We found that the signaling receptor Notch2 controlled the terminal stage of cDC differentiation. Notch2-dependent intestinal CD11b(+) cDCs were an obligate source of IL-23 required for survival after infection with C. rodentium, but CD103(+) cDCs dependent on the transcription factor Batf3 were not. Our results demonstrate a nonredundant function for CD11b(+) cDCs in the response to pathogens in vivo.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23913046      PMCID: PMC3788683          DOI: 10.1038/ni.2679

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  63 in total

1.  Dendritic cells produce CXCL13 and participate in the development of murine small intestine lymphoid tissues.

Authors:  Keely G McDonald; Jacquelyn S McDonough; Brian K Dieckgraefe; Rodney D Newberry
Journal:  Am J Pathol       Date:  2010-03-19       Impact factor: 4.307

Review 2.  Notch signaling in the immune system.

Authors:  Freddy Radtke; Nicolas Fasnacht; H Robson Macdonald
Journal:  Immunity       Date:  2010-01-29       Impact factor: 31.745

3.  Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual.

Authors:  Melissa Swiecki; Susan Gilfillan; William Vermi; Yaming Wang; Marco Colonna
Journal:  Immunity       Date:  2010-12-02       Impact factor: 31.745

4.  Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection.

Authors:  Yugang Wang; Ekaterina P Koroleva; Andrei A Kruglov; Dmitry V Kuprash; Sergei A Nedospasov; Yang-Xin Fu; Alexei V Tumanov
Journal:  Immunity       Date:  2010-03-11       Impact factor: 31.745

Review 5.  Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity.

Authors:  Marco Colonna
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

6.  Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells.

Authors:  Brian T Edelson; Wumesh KC; Richard Juang; Masako Kohyama; Loralyn A Benoit; Paul A Klekotka; Clara Moon; Jörn C Albring; Wataru Ise; Drew G Michael; Deepta Bhattacharya; Thaddeus S Stappenbeck; Michael J Holtzman; Sun-Sang J Sung; Theresa L Murphy; Kai Hildner; Kenneth M Murphy
Journal:  J Exp Med       Date:  2010-03-29       Impact factor: 14.307

7.  Origin of the lamina propria dendritic cell network.

Authors:  Milena Bogunovic; Florent Ginhoux; Julie Helft; Limin Shang; Daigo Hashimoto; Melanie Greter; Kang Liu; Claudia Jakubzick; Molly A Ingersoll; Marylene Leboeuf; E Richard Stanley; Michel Nussenzweig; Sergio A Lira; Gwendalyn J Randolph; Miriam Merad
Journal:  Immunity       Date:  2009-09-10       Impact factor: 31.745

8.  Intestinal lamina propria dendritic cell subsets have different origin and functions.

Authors:  Chen Varol; Alexandra Vallon-Eberhard; Eran Elinav; Tegest Aychek; Yami Shapira; Hervé Luche; Hans Jörg Fehling; Wolf-Dietrich Hardt; Guy Shakhar; Steffen Jung
Journal:  Immunity       Date:  2009-09-03       Impact factor: 31.745

9.  A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity.

Authors:  Marina Cella; Anja Fuchs; William Vermi; Fabio Facchetti; Karel Otero; Jochen K M Lennerz; Jason M Doherty; Jason C Mills; Marco Colonna
Journal:  Nature       Date:  2008-11-02       Impact factor: 49.962

10.  RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells.

Authors:  Stephanie L Sanos; Viet L Bui; Arthur Mortha; Karin Oberle; Charlotte Heners; Caroline Johner; Andreas Diefenbach
Journal:  Nat Immunol       Date:  2008-11-23       Impact factor: 25.606

View more
  191 in total

1.  Targeting cellular fatty acid synthesis limits T helper and innate lymphoid cell function during intestinal inflammation and infection.

Authors:  Panagiota Mamareli; Friederike Kruse; Chia-Wen Lu; Melanie Guderian; Stefan Floess; Katharina Rox; David S J Allan; James R Carlyle; Mark Brönstrup; Rolf Müller; Luciana Berod; Tim Sparwasser; Matthias Lochner
Journal:  Mucosal Immunol       Date:  2020-04-30       Impact factor: 7.313

2.  DCs: a dual bridge to protective immunity.

Authors:  Federica Sallusto
Journal:  Nat Immunol       Date:  2013-09       Impact factor: 25.606

Review 3.  Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity.

Authors:  D J Silberger; C L Zindl; C T Weaver
Journal:  Mucosal Immunol       Date:  2017-06-14       Impact factor: 7.313

Review 4.  Intestinal Antigen-Presenting Cells: Key Regulators of Immune Homeostasis and Inflammation.

Authors:  Kyle L Flannigan; Duke Geem; Akihito Harusato; Timothy L Denning
Journal:  Am J Pathol       Date:  2015-05-11       Impact factor: 4.307

5.  Transcription factor Zeb2 regulates commitment to plasmacytoid dendritic cell and monocyte fate.

Authors:  Xiaodi Wu; Carlos G Briseño; Gary E Grajales-Reyes; Malay Haldar; Arifumi Iwata; Nicole M Kretzer; Wumesh Kc; Roxane Tussiwand; Yujiro Higashi; Theresa L Murphy; Kenneth M Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-05       Impact factor: 11.205

6.  CCR6 promotes steady-state mononuclear phagocyte association with the intestinal epithelium, imprinting and immune surveillance.

Authors:  Keely G McDonald; Leroy W Wheeler; Jeremiah R McDole; Shannon Joerger; Jenny K Gustafsson; Devesha H Kulkarni; Kathryn A Knoop; Ifor R Williams; Mark J Miller; Rodney D Newberry
Journal:  Immunology       Date:  2017-08-30       Impact factor: 7.397

Review 7.  Development of conventional dendritic cells: from common bone marrow progenitors to multiple subsets in peripheral tissues.

Authors:  D Sichien; B N Lambrecht; M Guilliams; C L Scott
Journal:  Mucosal Immunol       Date:  2017-02-15       Impact factor: 7.313

8.  The cellular and molecular origin of tumor-associated macrophages.

Authors:  Ruth A Franklin; Will Liao; Abira Sarkar; Myoungjoo V Kim; Michael R Bivona; Kang Liu; Eric G Pamer; Ming O Li
Journal:  Science       Date:  2014-05-08       Impact factor: 47.728

9.  Limited Macrophage Positional Dynamics in Progressing or Regressing Murine Atherosclerotic Plaques-Brief Report.

Authors:  Jesse W Williams; Catherine Martel; Stephane Potteaux; Ekaterina Esaulova; Molly A Ingersoll; Andrew Elvington; Brian T Saunders; Li-Hao Huang; Andreas J Habenicht; Bernd H Zinselmeyer; Gwendalyn J Randolph
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-08       Impact factor: 8.311

10.  TAO-kinase 3 governs the terminal differentiation of NOTCH2-dependent splenic conventional dendritic cells.

Authors:  Matthias Vanderkerken; Bastiaan Maes; Lana Vandersarren; Wendy Toussaint; Kim Deswarte; Manon Vanheerswynghels; Philippe Pouliot; Liesbet Martens; Sofie Van Gassen; Connie M Arthur; Margaret E Kirkling; Boris Reizis; Daniel Conrad; Sean Stowell; Hamida Hammad; Bart N Lambrecht
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.